Exclusive Channel Partner Agreement Sample Contracts

Intrexon Corp – Exclusive Channel Partner Agreement (March 1st, 2017)

THIS EXCLUSIVE CHANNEL PARTNER AGREEMENT (the "Agreement") is made and entered into effective as of January 6, 2011 (the "Effective Date") by and between INTREXON CORPORATION, a Virginia corporation with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 ("Intrexon"), and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 ("ZIOPHARM"). Intrexon and ZIOPHARM may be referred to herein individually as a "Party", and collectively as the "Parties."

Exclusive Channel Partner Agreement (February 16th, 2017)

THIS EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Agreement) is made and entered into effective as of January 6, 2011 (the Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon), and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party, and collectively as the Parties.

Intrexon Corp – Third Amendment to Exclusive Channel Partner Agreement (June 30th, 2016)

This THIRD AMENDMENT TO THE EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Third Amendment) is effective as of June 29, 2016 (the Third Amendment Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon) and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party and collectively as the Parties.

Third Amendment to Exclusive Channel Partner Agreement (June 30th, 2016)

This THIRD AMENDMENT TO THE EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Third Amendment) is effective as of June 29, 2016 (the Third Amendment Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon) and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party and collectively as the Parties.

Intrexon Corp – Second Amendment to Exclusive Channel Partner Agreement (April 2nd, 2015)

This SECOND AMENDMENT TO THE EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Amendment) is effective as of March 27, 2015 (the Amendment Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon) and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party and collectively as the Parties.

Second Amendment to Exclusive Channel Partner Agreement (April 2nd, 2015)

This SECOND AMENDMENT TO THE EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Amendment) is effective as of March 27, 2015 (the Amendment Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon) and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party and collectively as the Parties.

Intrexon Corp – Exclusive Channel Partner Agreement (July 9th, 2013)

THIS EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Agreement) is made and entered into effective as of January 6, 2011 (the Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon), and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party, and collectively as the Parties.

Intrexon Corp – Exclusive Channel Partner Agreement (May 31st, 2013)

THIS EXCLUSIVE CHANNEL PARTNER AGREEMENT (the Agreement) is made and entered into effective as of January 6, 2011 (the Effective Date) by and between INTREXON CORPORATION, a Virginia corporation with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (Intrexon), and ZIOPHARM ONCOLOGY, INC., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (ZIOPHARM). Intrexon and ZIOPHARM may be referred to herein individually as a Party, and collectively as the Parties.

Exclusive Channel Partner Agreement (January 12th, 2011)

This Exclusive Channel Partner Agreement (the "Agreement") is made and entered into effective as of January 6, 2011 (the "Effective Date") by and between Intrexon Corporation, a Virginia corporation with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 ("Intrexon"), and ZIOPHARM Oncology, Inc., a Delaware corporation having its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 ("ZIOPHARM"). Intrexon and ZIOPHARM may be referred to herein individually as a "Party", and collectively as the "Parties."

Braintech – Exclusive Channel Partner Agreement for the Licensing of Braintech's Vision Guided Robotics Technologies and Software Products Parties: (January 19th, 2005)

BETWEEN: BRAINTECH CANADA INC., a corporation duly organized and existing under the laws of British Columbia, Canada, with its principal office at 102-930 West 1st Street, North Vancouver, British Columbia, Canada V7P 3N4: (604) 9886440, fax (604) 986-6131 (hereinafter referred to as "Braintech")

Braintech – Exclusive Channel Partner Agreement for the Licensing of Braintech's Vision Guided Robotics Technologies and Software Products Parties: (March 9th, 2004)